{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:10:06Z","timestamp":1751346606366,"version":"3.41.0"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The meninges serve as a protective layer, and the fluid around the brain and spinal\ncord can become inflamed, known as meningitis. Lipid-based pharmaceutical formulations, by\ntheir high lipophilicity, can negotiate the Blood-Brain Barrier (BBB). The current mode of\ntreatment of meningitis is mainly through antibiotics, which, at best, is partially effective. The\nsuccess of antibiotic therapy depends on several factors, for example, the difficulty of reaching\nthe infection site, maintaining proper concentrations of the drug after crossing the BBB, and\nfinally, its efficacy in preventing recurrent infection. In this context, interest has focused on organic\nand inorganic nanostructures for meningitis and transporting antibiotics to the selected\nregion through the BBB. A focus has also been placed on several polymeric nanotechnology\ntechniques for detecting various types of meningitis. This review focuses on nano interventions\nand their most recent meningitis treatments using nanotechnology.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010303028240429073144","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T07:21:12Z","timestamp":1714980072000},"page":"1362-1374","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanotechnology-powered Meningitis Therapies: Lipid Nanoparticles Lead the Way"],"prefix":"10.2174","volume":"26","author":[{"given":"Dipanjan","family":"Karati","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Technology, School of Pharmacy, Techno India University, Kolkata, 700091, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swarupananda","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Deprtment of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata - Group of Institutions, 124, B.L Saha\nRoad, Kolkata, 700053, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susmita","family":"Paul","sequence":"additional","affiliation":[{"name":"Deprtment of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata - Group of Institutions, 124, B.L Saha\nRoad, Kolkata, 700053, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchana","family":"Das","sequence":"additional","affiliation":[{"name":"Deprtment of Pharmaceutical Technology, NSHM Knowledge Campus, Kolkata - Group of Institutions, 124, B.L Saha\nRoad, Kolkata, 700053, West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupendra","family":"Prajapati","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Shree S. K. Patel College of\nPharmaceutical Education and Research, Ganpat University, Kherva, 384012, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravish J.","family":"Patel","sequence":"additional","affiliation":[{"name":"Ramanbhai Patel College of\nPharmacy, Charotar University of Science and Technology, CHARUSAT Campus, Changa, 388421, Anand, Gujarat,\nIndia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajal K.","family":"Jha","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Bengal College of Pharmaceutical Technology, Dubrajpur, 731123,\nWest Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1128\/CMR.00070-09","volume":"23","author":"Brouwer M.C.","year":"2010","unstructured":"Brouwer M.C.; Tunkel A.R.; van de Beek D.; Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev  2010,23(3),467-492","journal-title":"Clin Microbiol Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S1474-4422(06)70409-4","volume":"5","author":"Weisfelt M.","year":"2006","unstructured":"Weisfelt M.; de Gans J.; van der Poll T.; van de Beek D.; Pneumococcal meningitis in adults: New approaches to management and prevention. Lancet Neurol  2006,5(4),332-342","journal-title":"Lancet Neurol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2023.2545","volume":"329","author":"Ait-Ali Y.","year":"2023","unstructured":"Ait-Ali Y.; Bourlon L.; Jacobs F.M.; Review of progress and challenges in bacterial meningitis. JAMA  2023,329(16),1406","journal-title":"JAMA"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jemermed.2008.02.053","volume":"38","author":"Rafi W.","year":"2010","unstructured":"Rafi W.; Chandramuki A.; Mani R.; Satishchandra P.; Shankar S.K.; Rapid diagnosis of acute bacterial meningitis: role of a broad range 16S rRNA polymerase chain reaction. J Emerg Med  2010,38(2),225-230","journal-title":"J Emerg Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/brain\/awad089","volume":"146","author":"Petersen P.T.","year":"2023","unstructured":"Petersen P.T.; Bodilsen J.; Jepsen M.P.G.; Larsen L.; Storgaard M.; Hansen B.R.; Helweg-Larsen J.; Wiese L.; L\u00fcttichau H.R.; Andersen C.\u00d8.; Nielsen H.; Brandt C.T.; Clinical features and prognostic factors in adults with viral meningitis. Brain  2023,146(9),3816-3825","journal-title":"Brain"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.clinmicnews.2015.02.004","volume":"37","author":"Zueter A.M.","year":"2015","unstructured":"Zueter A.M.; Zaiter A.; Infectious Meningitis. Clin Microbiol Newsl  2015,37(6),43-51","journal-title":"Clin Microbiol Newsl"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/QCO.0000000000000541","volume":"32","author":"Bloch K.C.","year":"2019","unstructured":"Bloch K.C.; Bailin S.S.; Update on fungal infections of the central nervous system: Emerging pathogens and emerging diagnostics. Curr Opin Infect Dis  2019,32(3),277-284","journal-title":"Curr Opin Infect Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"acmi000158","DOI":"10.1099\/acmi.0.000158","volume":"2","author":"Ranson E.","year":"2020","unstructured":"Ranson E.; Ship H.; Garner O.; Yang S.; Bhattacharya D.; Unusual presentation of meningococcal meningitis in the elderly and utility of CSF PCR testing. Access Microbiol  2020,2(10),acmi000158","journal-title":"Access Microbiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"60459","DOI":"10.1007\/s11356-021-16570-y","volume":"28","author":"Sharma N.","year":"2021","unstructured":"Sharma N.; Zahoor I.; Sachdeva M.; Subramaniyan V.; Fuloria S.; Fuloria N.K.; Naved T.; Bhatia S.; Al-Harrasi A.; Aleya L.; Bungau S.; Behl T.; Singh S.; Deciphering the role of nanoparticles for management of bacterial meningitis: An update on recent studies. Environ Sci Pollut Res Int  2021,28(43),60459-60476","journal-title":"Environ Sci Pollut Res Int"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1468-1331.2008.02193.x","volume":"15","author":"Chaudhuri A.","year":"2008","unstructured":"Chaudhuri A.; Martin P.M.; Kennedy P.G.E.; Andrew Seaton R.; Portegies P.; Bojar M.; Steiner I.; EFNS guideline on the management of community\u2010acquired bacterial meningitis: Report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol  2008,15(7),649-659","journal-title":"Eur J Neurol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fcimb.2020.00463","volume":"10","author":"Kischkel B.","year":"2020","unstructured":"Kischkel B.; Rossi S.A.; Santos S.R.; Nosanchuk J.D.; Travassos L.R.; Taborda C.P.; Therapies and vaccines based on nanoparticles for the treatment of systemic fungal infections. Front Cell Infect Microbiol  2020,10,463","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/molecules26010186","volume":"26","author":"Barani M.","year":"2021","unstructured":"Barani M.; Mukhtar M.; Rahdar A.; Sargazi G.; Thysiadou A.; Kyzas G.Z.; Progress in the application of nanoparticles and graphene as drug carriers and on the diagnosis of brain infections. Molecules  2021,26(1),186","journal-title":"Molecules"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.nano.2014.12.014","volume":"11","author":"Gendelman H.E.","year":"2015","unstructured":"Gendelman H.E.; Anantharam V.; Bronich T.; Ghaisas S.; Jin H.; Kanthasamy A.G.; Liu X.; McMillan J.; Mosley R.L.; Narasimhan B.; Mallapragada S.K.; Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases. Nanomedicine  2015,11(3),751-767","journal-title":"Nanomedicine"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.anorl.2020.10.008","volume":"138","author":"Reynard P.","year":"2021","unstructured":"Reynard P.; Bascoul A.; Biotti D.; Karsenty J.; Ionescu E.; Thai-Van H.; Audiovestibular neuropathy in an immunocompetent man with cryptococcal meningitis. Eur Ann Otorhinolaryngol Head Neck Dis  2021,138(5),377-381","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2017.09.015","volume":"127","author":"Gao W.","year":"2018","unstructured":"Gao W.; Chen Y.; Zhang Y.; Zhang Q.; Zhang L.; Nanoparticle-based local antimicrobial drug delivery. Adv Drug Deliv Rev  2018,127,46-57","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/molecules22081370","volume":"22","author":"Aderibigbe B.","year":"2017","unstructured":"Aderibigbe B.; Metal-based nanoparticles for the treatment of infectious diseases. Molecules  2017,22(8),1370","journal-title":"Molecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1099\/mic.0.051524-0","volume":"158","author":"Stie J.","year":"2012","unstructured":"Stie J.; Fox D.; Blood\u2013brain barrier invasion by Cryptococcus neoformans is enhanced by functional interactions with plasmin. Microbiology  2012,158(1),240-258","journal-title":"Microbiology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3892\/etm.2017.4082","volume":"13","author":"Prager O.","year":"2017","unstructured":"Prager O.; Friedman A.; Nebenzahl Y.M.; Role of neural barriers in the pathogenesis and outcome of Streptococcus pneumoniae meningitis. Exp Ther Med  2017,13(3),799-809","journal-title":"Exp Ther Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.nantod.2014.06.003","volume":"9","author":"Zhu X.","year":"2014","unstructured":"Zhu X.; Radovic-Moreno A.F.; Wu J.; Langer R.; Shi J.; Nanomedicine in the management of microbial infection \u2013 Overview and perspectives. Nano Today  2014,9(4),478-498","journal-title":"Nano Today"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000112961","volume":"17","author":"Jain K.K.","year":"2008","unstructured":"Jain K.K.; Nanomedicine: Application of nanobiotechnology in medical practice. Med Princ Pract  2008,17(2),89-101","journal-title":"Med Princ Pract"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"103575","DOI":"10.1016\/j.jbi.2020.103575","volume":"111","author":"Ribeiro M.H.D.M.","year":"2020","unstructured":"Ribeiro M.H.D.M.; Mariani V.C.; Coelho L.S.; Multi-step ahead meningitis case forecasting based on decomposition and multi-objective optimization methods. J Biomed Inform  2020,111,103575","journal-title":"J Biomed Inform"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/869269","volume":"2014","author":"Upadhyay R.K.","year":"2014","unstructured":"Upadhyay R.K.; Drug delivery systems, CNS protection, and the blood brain barrier. BioMed Res Int  2014,2014,1-37","journal-title":"BioMed Res Int"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.addr.2016.02.008","volume":"103","author":"Nair M.","year":"2016","unstructured":"Nair M.; Jayant R.D.; Kaushik A.; Sagar V.; Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv Rev  2016,103,202-217","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=24","author":"Zeeshan M","year":"2019","unstructured":"Zeeshan M; Mukhtar M; Ain QU; Khan S; Ali H; Nanopharmaceuticals: A boon to the brain-targeted drug delivery. Pharmaceutical Formulation Design-Recent Practices  2019","journal-title":"Pharmaceutical Formulation Design-Recent Practices"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijpharm.2013.08.079","volume":"457","author":"Wacker M.","year":"2013","unstructured":"Wacker M.; Nanocarriers for intravenous injection\u2014The long hard road to the market. Int J Pharm  2013,457(1),50-62","journal-title":"Int J Pharm"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.2174\/1381612826999200820173253","volume":"26","author":"Jahangir M.A.","year":"2020","unstructured":"Jahangir M.A.; Taleuzzaman M.; Kala C.; Gilani S.J.; Advancements in polymer and lipid-based nanotherapeutics for cancer drug targeting. Curr Pharm Des  2020,26(40),5119-5127","journal-title":"Curr Pharm Des"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"783831","DOI":"10.3389\/fnut.2021.783831","volume":"8","author":"Lu H.","year":"2021","unstructured":"Lu H.; Zhang S.; Wang J.; Chen Q.; A review on polymer and lipid-based nanocarriers and its application to nano-pharmaceutical and food-based systems. Front Nutr  2021,8,783831","journal-title":"Front Nutr"},{"key":"ref=28","first-page":"289","volume":"2","author":"\u00dcner M.","year":"2007","unstructured":"\u00dcner M.; Yener G.; Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine  2007,2(3),289-300","journal-title":"Int J Nanomedicine"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1016\/j.biomaterials.2009.12.042","volume":"31","author":"Wang H.","year":"2010","unstructured":"Wang H.; Xu K.; Liu L.; Tan J.P.K.; Chen Y.; Li Y.; Fan W.; Wei Z.; Sheng J.; Yang Y.Y.; Li L.; The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. Biomaterials  2010,31(10),2874-2881","journal-title":"Biomaterials"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.2147\/DDDT.S102500","volume":"11","author":"Fatouh A.","year":"2017","unstructured":"Fatouh A.; Elshafeey A.; Abdelbary A.; Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics. Drug Des Devel Ther  2017,11,1815-1825","journal-title":"Drug Des Devel Ther"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12951-016-0177-x","volume":"14","author":"Neves A.R.","year":"2016","unstructured":"Neves A.R.; Queiroz J.F.; Reis S.; Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E. J Nanobiotechnology  2016,14(1),27","journal-title":"J Nanobiotechnology"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.2174\/1381612823666170727144450","volume":"23","author":"Veszelka S.","year":"2017","unstructured":"Veszelka S.; Meszaros M.; Kiss L.; Kota Z.; Pali T.; Hoyk Z.; Bozso Z.; Fulop L.; Toth A.; Rakhely G.; Deli M.A.; Biotin and glutathione targeting of solid nanoparticles to cross human brain endothelial cells. Curr Pharm Des  2017,23(28),4198-4205","journal-title":"Curr Pharm Des"},{"key":"ref=33","first-page":"182","author":"Jawetz E.","year":"2016","unstructured":"Jawetz E.; Adelberg E.A.; Carroll K.C.; Melnick J.L.;  Microbiolog\u00eda m\u00e9dica  2016,182-187","journal-title":"Microbiolog\u00eda m\u00e9dica"},{"key":"ref=34","first-page":"73","volume":"40","author":"Alfaro C.","year":"2005","unstructured":"Alfaro C.; Pathogenesis of Neisseria meningitidis. Rev M\u00e9d Hosp Nac Ni\u00f1os Dr Carlos Saenz Herrera  2005,40(2),73-80","journal-title":"Rev M\u00e9d Hosp Nac Ni\u00f1os Dr Carlos Saenz Herrera"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jconrel.2023.12.054","volume":"366","author":"Huang Q.","year":"2024","unstructured":"Huang Q.; Chen Y.; Zhang W.; Xia X.; Li H.; Qin M.; Gao H.; Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases. J Control Release  2024,366,519-534","journal-title":"J Control Release"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1341295","DOI":"10.3389\/fnagi.2023.1341295","volume":"15","author":"Huang Q.","year":"2024","unstructured":"Huang Q.; Chen X.; Yu S.; Gong G.; Shu H.; Research progress in brain-targeted nasal drug delivery. Front Aging Neurosci  2024,15,1341295","journal-title":"Front Aging Neurosci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1007\/s00289-022-04424-7","volume":"80","author":"Karati D.","year":"2023","unstructured":"Karati D.; A concise review on bio-responsive polymers in targeted drug delivery system. Polym Bull  2023,80(7),7023-7045","journal-title":"Polym Bull"},{"key":"ref=38","first-page":"67","volume":"8","author":"Patel V.","year":"2020","unstructured":"Patel V.; Liposome: A novel carrier for targeting drug delivery system. Asian J Pharm Res Dev  2020,8(4),67-76","journal-title":"Asian J Pharm Res Dev"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.addr.2007.10.008","volume":"60","author":"Torchilin V.P.","year":"2008","unstructured":"Torchilin V.P.; Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev  2008,60(4-5),548-558","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2147\/IJN.S130125","volume":"12","author":"Bartomeu Garcia C.","year":"2017","unstructured":"Bartomeu Garcia C.; Shi D.; Webster T.J.; Tat-functionalized liposomes for the treatment of meningitis: An in vitro study. Int J Nanomedicine  2017,12,3009-3021","journal-title":"Int J Nanomedicine"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11046-017-0240-7","volume":"183","author":"Stewart E.R.","year":"2018","unstructured":"Stewart E.R.; Eldridge M.L.; McHardy I.; Cohen S.H.; Thompson G.R.; Liposomal amphotericin B as monotherapy in relapsed coccidioidal meningitis. Mycopathologia  2018,183(3),619-622","journal-title":"Mycopathologia"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1155\/1998\/831425","volume":"9","author":"Zhanel G.G.","year":"1998","unstructured":"Zhanel G.G.; Simor A.E.; Vercaigne L.; Mandell L.; Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. Can J Infect Dis  1998,9(4),215-228","journal-title":"Can J Infect Dis"},{"key":"ref=43","first-page":"50","volume":"77","author":"Steele R.W.","year":"1984","unstructured":"Steele R.W.; Ceftriaxone therapy of meningitis and serious infections. Am J Med  1984,77(4C),50-53","journal-title":"Am J Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1208\/s12248-021-00648-z","volume":"23","author":"Juhairiyah F.","year":"2021","unstructured":"Juhairiyah F.; de Lange E.C.M.; Understanding drug delivery to the brain using liposome-based strategies: Studies that provide mechanistic insights are essential. AAPS J  2021,23(6),114","journal-title":"AAPS J"},{"key":"ref=45","first-page":"131","volume":"22","author":"Mukherjee S.","year":"2009","unstructured":"Mukherjee S.; Ray S.; Thakur R.S.; Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy. Pak J Pharm Sci  2009,22(2),131-138","journal-title":"Pak J Pharm Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/nano9030474","volume":"9","author":"Bay\u00f3n-Cordero L.","year":"2019","unstructured":"Bay\u00f3n-Cordero L.; Alkorta I.; Arana L.; Application of solid lipid nanoparticles to improve the efficiency of anticancer drugs. Nanomaterials  2019,9(3),474","journal-title":"Nanomaterials"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"111076","DOI":"10.1016\/j.colsurfb.2020.111076","volume":"193","author":"Abdel Hady M.","year":"2020","unstructured":"Abdel Hady M.; Sayed O.M.; Akl M.A.; Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation. Colloids Surf B Biointerfaces  2020,193,111076","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijpharm.2013.11.038","volume":"461","author":"Kumar M.","year":"2014","unstructured":"Kumar M.; Kakkar V.; Mishra A.K.; Chuttani K.; Kaur I.P.; Intranasal delivery of streptomycin sulfate (STRS) loaded solid lipid nanoparticles to brain and blood. Int J Pharm  2014,461(1-2),223-233","journal-title":"Int J Pharm"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1359-0286(02)00117-1","volume":"6","author":"Hans M.L.","year":"2002","unstructured":"Hans M.L.; Lowman A.M.; Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci  2002,6(4),319-327","journal-title":"Curr Opin Solid State Mater Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12668-019-00713-0","volume":"10","author":"Nair K.G.S.","year":"2020","unstructured":"Nair K.G.S.; Velmurugan R.; Sukumaran S.K.; Formulation and optimization of ansamycin-loaded polymeric nanoparticles using response surface methodology for bacterial meningitis. Bionanoscience  2020,10(1),279-291","journal-title":"Bionanoscience"},{"key":"ref=51","first-page":"4053","volume":"7","author":"Abdelghany S.M.","year":"2012","unstructured":"Abdelghany S.M.; Quinn D.J.; Ingram R.J.; Gilmore B.F.; Donnelly R.F.; Taggart C.C.; Scott C.J.; Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomedicine  2012,7,4053-4063","journal-title":"Int J Nanomedicine"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12951-021-00812-9","volume":"19","author":"Zhang J.","year":"2021","unstructured":"Zhang J.; Sun H.; Gao C.; Wang Y.; Cheng X.; Yang Y.; Gou Q.; Lei L.; Chen Y.; Wang X.; Zou Q.; Gu J.; Development of a chitosan\u2010modified PLGA nanoparticle vaccine for protection against Escherichia coli K1 caused meningitis in mice. J Nanobiotechnology  2021,19(1),69","journal-title":"J Nanobiotechnology"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2147\/IJN.S17503","volume":"6","author":"Xu N.","year":"2011","unstructured":"Xu N.; Julin G.; Yuanjie Z.; Hai W.; Qiushi R.; Jianghan C.; Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice. Int J Nanomedicine  2011,6,905-913","journal-title":"Int J Nanomedicine"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1080\/10717544.2018.1486473","volume":"25","author":"Hong W.","year":"2018","unstructured":"Hong W.; Zhang Z.; Liu L.; Zhao Y.; Zhang D.; Liu M.; Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG  and Pluronic  P85 unimers. Drug Deliv  2018,25(1),1886-1897","journal-title":"Drug Deliv"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2147\/IJN.S61288","volume":"9","author":"Lu C.T.","year":"2014","unstructured":"Lu C.T.; Zhao Y.Z.; Wong H.L.; Cai J.; Peng L.; Tian X.Q.; Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomedicine  2014,9,2241-2257","journal-title":"Int J Nanomedicine"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijpharm.2014.04.027","volume":"468","author":"Beloqui A.","year":"2014","unstructured":"Beloqui A.; Solin\u00eds M.\u00c1.; Rieux A.; Pr\u00e9at V.; Rodr\u00edguez-Gasc\u00f3n A.; Dextran\u2013protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs. Int J Pharm  2014,468(1-2),105-111","journal-title":"Int J Pharm"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"Naseri N.","year":"2015","unstructured":"Naseri N.; Valizadeh H.; Zakeri-Milani P.; Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application. Adv Pharm Bull  2015,5(3),305-313","journal-title":"Adv Pharm Bull"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jconrel.2014.03.055","volume":"190","author":"Forier K.","year":"2014","unstructured":"Forier K.; Raemdonck K.; De Smedt S.C.; Demeester J.; Coenye T.; Braeckmans K.; Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release  2014,190,607-623","journal-title":"J Control Release"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/pharmaceutics12070678","volume":"12","author":"Rinaldi F.","year":"2020","unstructured":"Rinaldi F.; Oliva A.; Sabatino M.; Imbriano A.; Hanieh P.N.; Garzoli S.; Mastroianni C.M.; De Angelis M.; Miele M.C.; Arnaut M.; Di Timoteo F.; Marianecci C.; Ragno R.; Carafa M.; Antimicrobial essential oil formulation: Chitosan coated nanoemulsions for nose to brain delivery. Pharmaceutics  2020,12(7),678","journal-title":"Pharmaceutics"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.2147\/IJN.S151788","volume":"13","author":"Harun S.","year":"2018","unstructured":"Harun S.; Amin Nordin S.; Abd Gani S.S.; Shamsuddin A.F.; Basri M.; Bin Basri H.; Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: Designs, characterizations, and pharmacokinetics. Int J Nanomedicine  2018,13,2571-2584","journal-title":"Int J Nanomedicine"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.colsurfb.2013.07.043","volume":"112","author":"Musa S.H.","year":"2013","unstructured":"Musa S.H.; Basri M.; Masoumi H.R.F.; Karjiban R.A.; Malek E.A.; Basri H.; Shamsuddin A.F.; Formulation optimization of palm kernel oil esters nanoemulsion-loaded with chloramphenicol suitable for meningitis treatment. Colloids Surf B Biointerfaces  2013,112,113-119","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2217\/nnm-2017-0365","volume":"13","author":"Shobo A.","year":"2018","unstructured":"Shobo A.; Pamreddy A.; Kruger H.G.; Makatini M.M.; Naicker T.; Govender T.; Baijnath S.; Enhanced brain penetration of pretomanid by intranasal administration of an oil-in-water nanoemulsion. Nanomedicine  2018,13(9),997-1008","journal-title":"Nanomedicine"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2147\/IDR.S168868","volume":"11","author":"Pompilio A.","year":"2018","unstructured":"Pompilio A.; Geminiani C.; Mantini P.; Siriwardena T.N.; Di Bonaventura I.; Reymond J.L.; Di Bonaventura G.; Peptide dendrimers as \u201clead compounds\u201d for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies. Infect Drug Resist  2018,11,1767-1782","journal-title":"Infect Drug Resist"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.addr.2012.09.030","volume":"64","author":"Svenson S.","year":"2012","unstructured":"Svenson S.; Tomalia D.A.; Dendrimers in biomedical applications\u2014reflections on the field. Adv Drug Deliv Rev  2012,64,102-115","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.3390\/molecules22101581","volume":"22","author":"Garc\u00eda-Gallego S.","year":"2017","unstructured":"Garc\u00eda-Gallego S.; Franci G.; Falanga A.; G\u00f3mez R.; Folliero V.; Galdiero S.; de la Mata F.; Galdiero M.; Function oriented molecular design: Dendrimers as novel antimicrobials. Molecules  2017,22(10),1581","journal-title":"Molecules"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/molecules22060868","volume":"22","author":"Ladd E.","year":"2017","unstructured":"Ladd E.; Sheikhi A.; Li N.; van de Ven T.; Kakkar A.; Design and synthesis of dendrimers with facile surface group functionalization, and an evaluation of their bactericidal efficacy. Molecules  2017,22(6),868","journal-title":"Molecules"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1007\/s10904-021-01925-2","volume":"31","author":"Nikzamir M.","year":"2021","unstructured":"Nikzamir M.; Hanifehpour Y.; Akbarzadeh A.; Panahi Y.; Applications of dendrimers in nanomedicine and drug delivery: A review. J Inorg Organomet Polym Mater  2021,31(6),2246-2261","journal-title":"J Inorg Organomet Polym Mater"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3390\/molecules23092205","volume":"23","author":"Mhlwatika Z.","year":"2018","unstructured":"Mhlwatika Z.; Aderibigbe B.; Application of dendrimers for the treatment of infectious diseases. Molecules  2018,23(9),2205","journal-title":"Molecules"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-29207-2_1","volume":"39","author":"Kumari P.","year":"2020","unstructured":"Kumari P.; Luqman S.; Meena A.; Nanomaterials: A promising tool for drug delivery. Environmental Chemistry for a Sustainable World  2020,39,1-49","journal-title":"Environmental Chemistry for a Sustainable World"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1295\/polymj.17.117","volume":"17","author":"Tomalia D.A.","year":"1985","unstructured":"Tomalia D.A.; Baker H.; Dewald J.; Hall M.; Kallos G.; Martin S.; Roeck J.; Ryder J.; Smith P.; A new class of polymers: Starburst-dendritic macromolecules. Polym J  1985,17(1),117-132","journal-title":"Polym J"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ijpharm.2018.07.030","volume":"548","author":"Sherje A.P.","year":"2018","unstructured":"Sherje A.P.; Jadhav M.; Dravyakar B.R.; Kadam D.; Dendrimers: A versatile nanocarrier for drug delivery and targeting. Int J Pharm  2018,548(1),707-720","journal-title":"Int J Pharm"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3390\/pharmaceutics14020224","volume":"14","author":"Ayub A.","year":"2022","unstructured":"Ayub A.; Wettig S.; An overview of nanotechnologies for drug delivery to the brain. Pharmaceutics  2022,14(2),224","journal-title":"Pharmaceutics"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.3390\/molecules25173982","volume":"25","author":"Chis A.A.","year":"2020","unstructured":"Chis A.A.; Dobrea C.; Morgovan C.; Arseniu A.M.; Rus L.L.; Butuca A.; Juncan A.M.; Totan M.; Vonica-Tincu A.L.; Cormos G.; Muntean A.C.; Muresan M.L.; Gligor F.G.; Frum A.; Applications and limitations of dendrimers in biomedicine. Molecules  2020,25(17),3982","journal-title":"Molecules"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/jps.24298","volume":"104","author":"Kalhapure R.S.","year":"2015","unstructured":"Kalhapure R.S.; Suleman N.; Mocktar C.; Seedat N.; Govender T.; Nanoengineered drug delivery systems for enhancing antibiotic therapy. J Pharm Sci  2015,104(3),872-905","journal-title":"J Pharm Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/molecules25061389","volume":"25","author":"Svenningsen S.W.","year":"2020","unstructured":"Svenningsen S.W.; Frederiksen R.F.; Counil C.; Ficker M.; Leisner J.J.; Christensen J.B.; Synthesis and antimicrobial properties of a ciprofloxacin and PAMAM-dendrimer conjugate. Molecules  2020,25(6),1389","journal-title":"Molecules"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.3390\/ijms22062912","volume":"22","author":"Tarach P.","year":"2021","unstructured":"Tarach P.; Janaszewska A.; Recent advances in preclinical research using PAMAM dendrimers for cancer gene therapy. Int J Mol Sci  2021,22(6),2912","journal-title":"Int J Mol Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2478\/fv-2023-0014","volume":"67","author":"Kuckov\u00e1 K.","year":"2023","unstructured":"Kuckov\u00e1 K.; Bhide M.; Dendrimers as antimicrobial agents in the central nervous system infections. A review. Folia Vet  2023,67(2),24-32","journal-title":"Folia Vet"},{"key":"ref=78","first-page":"204","volume":"2","author":"Walve JR","year":"2011","unstructured":"Walve JR; Bakliwal SR; Rane BR; Pawar SP; Transfersomes: A surrogated carrier for transdermal drug delivery system. Int J Appl Biol Pharm Technol  2011,2(1),204-213","journal-title":"Int J Appl Biol Pharm Technol"},{"key":"ref=79","first-page":"28","volume":"15","author":"Rada S.K.","year":"2023","unstructured":"Rada S.K.; Pola K.K.; An overview on ultra deformable vesicular drug delivery systems in transdermal drug delivery. Int J Appl Pharm  2023,15,28-34","journal-title":"Int J Appl Pharm"},{"key":"ref=80","first-page":"309","volume":"2","author":"Sachan R.","year":"2013","unstructured":"Sachan R.; Parashar T.; Soniya S.V.; Singh G.; Tyagi S.; Patel C.; Gupta A.; Drug carrier transfersomes: A novel tool for transdermal drug delivery system. IJRDPLS  2013,2(2),309-316","journal-title":"IJRDPLS"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ajps.2013.09.005","volume":"8","author":"Lei W.","year":"2013","unstructured":"Lei W.; Yu C.; Lin H.; Zhou X.; Development of tacrolimus-loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo. Asian J Pharm Sci  2013,8(6),336-345","journal-title":"Asian J Pharm Sci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2329-9053.1000113","volume":"2","author":"Pandey A.","year":"2014","unstructured":"Pandey A.; Mittal A.; Chauhan N.; Alam S.; Role of surfactants as penetration enhancer in transdermal drug delivery system. J Mol Pharm Org Process Res  2014,2(2),2-7","journal-title":"J Mol Pharm Org Process Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.jddst.2019.101304","volume":"54","author":"Eid H.M.","year":"2019","unstructured":"Eid H.M.; Elkomy M.H.; El Menshawe S.F.; Salem H.F.; Transfersomal nanovesicles for nose-to-brain delivery of ofloxacin for better management of bacterial meningitis: Formulation, optimization by Box-Behnken design, characterization and in vivo pharmacokinetic study. J Drug Deliv Sci Technol  2019,54,101304","journal-title":"J Drug Deliv Sci Technol"},{"year":"2020","author":"Babiychuk E.","key":"ref=84","unstructured":"Babiychuk E.; Draeger A.; Bern Universitaet, assignee. Tailored liposomes for the treatment of bacterial infections.  2020"},{"year":"2019","author":"Hauser","key":"ref=85","unstructured":"Hauser ; Antibiotic - coated nanoparticles.  2019"},{"year":"2007","author":"Young T.D.S.","key":"ref=86","unstructured":"Young T.D.S.; Novel nanoparticles and use thereof - Google Patents.  2007"},{"year":"2010","author":"Navai C.A.M.A.G.","key":"ref=87","unstructured":"Navai C.A.M.A.G.; Inhibition of Bacterial Protein Production by Polyvalent Oligonucleotide Modified Nanoparticle Conjugates - Google Patents.  2010"},{"year":"2004","author":"Martin","key":"ref=88","unstructured":"Martin ; Pharmaceutical compositions.  2004"},{"year":"2017","author":"Khan","key":"ref=89","unstructured":"Khan ; Compositions and methods for modified denormernanoparticle delivery.  2017"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"11759","DOI":"10.1007\/s00289-022-04661-w","volume":"80","author":"Chakraborty M.","year":"2023","unstructured":"Chakraborty M.; Banerjee D.; Mukherjee S.; Karati D.; Exploring the advancement of polymer-based nano-formulations for ocular drug delivery systems: an explicative review. Polym Bull  2023,80(11),11759-11777","journal-title":"Polym Bull"},{"key":"ref=91","first-page":"1","volume":"\u2022","author":"Bag J.","year":"2023","unstructured":"Bag J.; Mukherjee S.; Karati D.; Recent advancement of nanostructured materials: A compatible therapy of tissue engineering and drug delivery system. Polym Bull  2023,\u2022,1-24","journal-title":"Polym Bull"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2217\/nnm-2019-0130","volume":"14","author":"Bosetti R.","year":"2019","unstructured":"Bosetti R.; Jones S.L.; Cost\u2013effectiveness of nanomedicine: Estimating the real size of nano-costs. Nanomedicine  2019,14(11),1367-1370","journal-title":"Nanomedicine"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1021\/acs.nanolett.0c00620","volume":"20","author":"Richardson J.J.","year":"2020","unstructured":"Richardson J.J.; Caruso F.; Nanomedicine toward 2040. Nano Lett  2020,20(3),1481-1482","journal-title":"Nano Lett"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/17425247.2020.1758665","volume":"17","author":"Saleem S.","year":"2020","unstructured":"Saleem S.; Iqubal M.K.; Garg S.; Ali J.; Baboota S.; Trends in nanotechnology-based delivery systems for dermal targeting of drugs: An enticing approach to offset psoriasis. Expert Opin Drug Deliv  2020,17(6),817-838","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.colsurfb.2013.12.013","volume":"115","author":"Ahmad N.","year":"2014","unstructured":"Ahmad N.; Ramsch R.; Llin\u00e0s M.; Solans C.; Hashim R.; Tajuddin H.A.; Influence of nonionic branched-chain alkyl glycosides on a model nano-emulsion for drug delivery systems. Colloids Surf B Biointerfaces  2014,115,267-274","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jcis.2016.06.047","volume":"479","author":"Bai L.","year":"2016","unstructured":"Bai L.; McClements D.J.; Formation and stabilization of nanoemulsions using biosurfactants: Rhamnolipids. J Colloid Interface Sci  2016,479,71-79","journal-title":"J Colloid Interface Sci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1080\/17458080.2016.1212407","volume":"11","author":"Behalo M.S.","year":"2016","unstructured":"Behalo M.S.; Bloise E.; Carbone L.; Sole R.D.; Lomonaco D.; Mazzetto S.E.; Mele G.; Mergola L.; Cardanol-based green nanovesicles with antioxidant and cytotoxic activities. J Exp Nanosci  2016,11(16),1274-1284","journal-title":"J Exp Nanosci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s11743-015-1746-y","volume":"18","author":"Mak O.W.","year":"2015","unstructured":"Mak O.W.; Seman N.; Harun N.H.; Hussen R.S.D.; Rodzi N.M.; Heidelberg T.; Nanovesicles based on mixtures of a biantennary glycolipid with ionic co-surfactants. J Surfactants Deterg  2015,18(6),973-980","journal-title":"J Surfactants Deterg"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.foodchem.2019.04.090","volume":"293","author":"Sedaghat Doost A.","year":"2019","unstructured":"Sedaghat Doost A.; Van Camp J.; Dewettinck K.; Van der Meeren P.; Production of thymol nanoemulsions stabilized using Quillaja Saponin as a biosurfactant: Antioxidant activity enhancement. Food Chem  2019,293,134-143","journal-title":"Food Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"101451","DOI":"10.1016\/j.jddst.2019.101451","volume":"55","author":"Mukherjee S.","year":"2020","unstructured":"Mukherjee S.; Maity S.; Ghosh B.; Chakraborty T.; Mondal A.; Bishayee A.; Assessment of the antidiabetic potentiality of glyburide loaded glyceryl monostearate solid lipid nanoparticles. J Drug Deliv Sci Technol  2020,55,101451","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41586-024-07130-8","volume":"628","author":"Yin X.","year":"2024","unstructured":"Yin X.; Zhang S.; Lee J.H.; Dong H.; Mourgkos G.; Terwilliger G.; Kraus A.; Geraldo L.H.; Poulet M.; Fischer S.; Zhou T.; Mohammed F.S.; Zhou J.; Wang Y.; Malloy S.; Rohner N.; Sharma L.; Salinas I.; Eichmann A.; Thomas J.L.; Saltzman W.M.; Huttner A.; Zeiss C.; Ring A.; Iwasaki A.; Song E.; Compartmentalized ocular lymphatic system mediates eye\u2013brain immunity. Nature  2024,628(8006),204-211","journal-title":"Nature"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010303028240429073144","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/229676\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010303028240429073144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T04:45:30Z","timestamp":1751345130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/229676\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010303028240429073144","relation":{},"ISSN":["1389-2010"],"issn-type":[{"type":"print","value":"1389-2010"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}